In human pancreatic (PANC-1) and colorectal (HT-29) adenocarcinoma cell lines, NDRG1 markedly reduced total EGFR levels, inhibited EGFR dimerization and activation, and lowered EGFR phosphorylation even in the presence of EGF [34]. Here, EGFR is linked to adenocarcinoma.